Have your own idea? Try our Stock Screener
Polish (WIG) Clinical Research and Equipment Industry Analysis
UpdatedMay 01, 2026
DataAggregated Company Financials
Companies4
- 7D0.7%
- 3M-12.5%
- 1Y-11.6%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.3%, driven by declines from every company within the industry. The industry has fallen 13% in the last year. As for the next few years, earnings are expected to grow by 34% per annum.
Industry Valuation and Performance
Has the Polish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 01 May 2026 | zł1.3b | zł459.0m | -zł112,091,596.00 | 790.2x | -11.9x | 2.9x |
| Sun, 29 Mar 2026 | zł1.2b | zł461.9m | -zł107,178,157.00 | n/a | -10.8x | 2.5x |
| Tue, 24 Feb 2026 | zł1.5b | zł464.6m | -zł124,641,157.00 | n/a | -11.7x | 3.1x |
| Thu, 22 Jan 2026 | zł1.5b | zł464.6m | -zł124,641,157.00 | n/a | -11.7x | 3.1x |
| Sat, 20 Dec 2025 | zł1.4b | zł464.6m | -zł124,641,157.00 | n/a | -11x | 2.9x |
| Mon, 17 Nov 2025 | zł1.3b | zł504.3m | -zł114,614,851.00 | 1630.3x | -11.6x | 2.6x |
| Wed, 15 Oct 2025 | zł1.3b | zł507.6m | -zł114,663,001.00 | 1369.8x | -11.5x | 2.6x |
| Fri, 12 Sep 2025 | zł1.5b | zł460.9m | -zł129,094,851.00 | 37.8x | -11.6x | 3.3x |
| Sun, 10 Aug 2025 | zł1.5b | zł461.1m | -zł128,888,382.00 | 39.1x | -11.7x | 3.3x |
| Tue, 08 Jul 2025 | zł1.4b | zł461.1m | -zł128,888,382.00 | 33.4x | -11.1x | 3.1x |
| Thu, 05 Jun 2025 | zł1.4b | zł457.8m | -zł130,948,382.00 | n/a | -10.5x | 3x |
| Sat, 03 May 2025 | zł1.6b | zł452.3m | -zł123,092,243.00 | 49.3x | -13x | 3.5x |
| Mon, 31 Mar 2025 | zł1.6b | zł452.3m | -zł123,092,243.00 | 49.3x | -13x | 3.5x |
| Wed, 26 Feb 2025 | zł1.6b | zł427.2m | -zł63,400,243.00 | 15.8x | -25.1x | 3.7x |
| Fri, 24 Jan 2025 | zł1.7b | zł427.0m | -zł65,964,174.00 | 15.6x | -26.5x | 4.1x |
| Sun, 22 Dec 2024 | zł2.0b | zł427.0m | -zł65,964,174.00 | 16x | -29.8x | 4.6x |
| Tue, 19 Nov 2024 | zł2.3b | zł421.9m | -zł72,811,689.00 | 20.7x | -31x | 5.3x |
| Thu, 17 Oct 2024 | zł2.5b | zł413.2m | -zł64,500,689.00 | 24.2x | -38.6x | 6x |
| Sat, 14 Sep 2024 | zł2.5b | zł421.4m | -zł39,488,869.00 | 18x | -62.7x | 5.9x |
| Mon, 12 Aug 2024 | zł2.4b | zł413.4m | -zł36,839,029.00 | 17.8x | -65.6x | 5.8x |
| Wed, 10 Jul 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 19.6x | -77.7x | 6x |
| Fri, 07 Jun 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 18.6x | -78.7x | 6.1x |
| Sun, 05 May 2024 | zł2.5b | zł421.0m | -zł26,364,957.00 | 18.5x | -94.5x | 5.9x |
| Tue, 02 Apr 2024 | zł2.6b | zł421.0m | -zł26,364,957.00 | 17.5x | -97.7x | 6.1x |
| Thu, 29 Feb 2024 | zł2.5b | zł495.9m | -zł52,637,957.00 | 44.4x | -47.9x | 5.1x |
| Sat, 27 Jan 2024 | zł2.4b | zł495.2m | -zł50,454,191.00 | 43.8x | -47.9x | 4.9x |
| Mon, 25 Dec 2023 | zł2.6b | zł495.2m | -zł50,454,191.00 | 45.6x | -51.4x | 5.2x |
| Wed, 22 Nov 2023 | zł2.6b | zł484.4m | -zł46,593,727.00 | 51.1x | -54.8x | 5.3x |
| Fri, 20 Oct 2023 | zł3.0b | zł512.0m | -zł37,354,934.00 | 33.8x | -79.4x | 5.8x |
| Sun, 17 Sep 2023 | zł2.9b | zł515.2m | -zł42,853,934.00 | 42.7x | -68.2x | 5.7x |
| Tue, 15 Aug 2023 | zł2.8b | zł512.4m | -zł61,559,268.00 | 47.3x | -46.2x | 5.5x |
| Thu, 13 Jul 2023 | zł2.8b | zł512.4m | -zł61,559,268.00 | 46.3x | -45.8x | 5.5x |
| Sat, 10 Jun 2023 | zł2.9b | zł512.4m | -zł61,599,797.00 | 46.4x | -46.5x | 5.6x |
| Mon, 08 May 2023 | zł2.8b | zł505.4m | -zł64,921,034.00 | 66.6x | -43x | 5.5x |
Price to Earnings Ratio
-43x
Current Industry PE
- Investors are pessimistic on the Polish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.5x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 3.2% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does Polish Clinical Research and Equipment compare with similar industries?
| PL Market | -2.04% | |
| Healthcare | 0.31% | |
| Life Sciences | 0.68% | |
| Clinical Research and Equipment | 0.68% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RVU Ryvu Therapeutics | zł24.00 | 2.1% +zł11.6m | -25.9% | PS6.3x |